Failed Leadership, Late Assistance Behind India’s COVID Crisis, Experts Say
India is the epicenter of the COVID-19 pandemic.
Topic Coronavirus
Duke scholars are working to advance our understanding of COVID-19, from basic science to translational medicine to clinical care—as well as to address concerns related to the pandemic from a variety of disciplines.
Top Story
Recent Stories
-
Updated Masking Requirements on Campus
Effective immediately, Duke University will not require students, employees or visitors to wear masks or face coverings while outdoors, with the exception of crowded areas and gatherings where social distancing is not possible.
-
Global Health
Infectious Diseases, Pandemic Threats and Prevention Gregory Gray, professor of medicine, global health and environmental health.
-
One Student, Three Faculty/Staff Test Positive for COVID, April 19-25
Duke University’s comprehensive COVID-19 testing and contact tracing program administered 18,387 tests to 9,925 students and 2,124 tests to 1,127 faculty/staff for the period April 19-25, with a total of four positive results.
-
Duke Health Pauses Use of J&J Vaccines
Experts cautioned against seeing the six recent cases of serious reactions as a reason to avoid vaccinations
-
Student Vaccination Requirements for Fall Semester
Dear Colleagues, As you all know, the success of our pandemic response has relied on a number of different approaches for combating COVID-19—social distancing and de-densification, enhanced cleaning and controlled facilities access, restrictions on visitors and events, and the expectations outlined in the Duke Compact.
-
Vaccines: Herd Immunity, Passports, Reaching the Underserved
Three Duke experts examine pressing vaccination issues for the media
-
'Today Is a Great Day!' Student Immunizations Get Underway
Video of “Today is a great day!” | Student Immunizations Underway Duke students express their excitement as vaccinations begin for students at Blue Devil Tower.
-
Duke to Distribute New Federal Emergency Grants for Students
Part of the Coronavirus Response and Relief Supplemental Appropriations Act (CRRSAA), also known as Higher Education Emergency Relief Funds (HEERF II)
-
Duke Enrolls First-in-Nation Children for Pfizer-BioNTech U.S. Clinical Study Trial in Children Under 12
-
Duke Gardens to Begin Phased Reopening Thursday for Duke Faculty, Staff and Students
Video of Cherry Alleé, Sarah P. Duke gardens After a year-long closure because of the COVID-19 pandemic, Sarah P. Duke Gardens plans to reopen in phases beginning April 1, with limited capacity and timed ticketing to ensure best practices for health and safety.
In the News
COVID in India
Commentary by Kenneth Surin, professor emeritus of literature
Burnout Boom: 9 Ways to Protect Your High-Potentials
Commentary by Alain Hunkins of the New Delhi Institute of Management and a faculty member at Duke Corporate Education
Waiving Vaccine Patents Doesn’t Quickly Fix the World’s Shortage
Quotes Krishna Udayakumar, director of the Duke Global Health Innovation Center.
How Theater Can Help Us Survive
Commentary by Ariel Dorfman, a distinguished professor emeritus of literature at Duke
Uptick in Viral Infections Likely as Society Returns to ‘Normal,’ Duke Doctors Say
Interview with Dr. Becky Smith, an infectious diseases specialist at Duke University Hospital
Months Into Vaccinations, COVID-19 Outbreaks Still a Problem at Long-Term Care Facilities in NC
Interview with School of Medicine infectious disease specialist Dr. Cameron Wolfe
FDA Preparing to Approve Pfizer Vaccine for Children
Quotes Dr. Richard Chung, Duke Health pediatrician
Triangle Vaccine Providers Ready to Vaccinate Kids 12-15 Years Old When FDA Gives the Go-Ahead
Interviews with Dr. Thomas Holland, an infectious disease specialist at Duke, and his daughter Sophie, 12
Q&A With Duke Expert: How to Talk to Children About the COVID-19 Vaccine
Interview with Dr. Adia Ross, assistant professor of medicine and medical director for Duke Raleigh Hospital
COVID-19 Vaccine: What Is Difference Between Full and Emergency Approval by the FDA?
Interview with Dr. Susanna Naggie, vice dean for clinical research at the Duke University School of Medicine